SNDX Stock Analysis: Buy, Sell, or Hold?
SNDX - Syndax Pharmaceuticals, Inc.
$19.75
-1.02 (-4.91%)
▼
5d:
+3.51%
30d:
-10.43%
90d:
-1.89%
HOLD
MODERATE Confidence
Analysis Updated: Aug 20, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $19.75, which is considered slightly low relative to its 30-day fair value range of $19.50 to $23.11. From a valuation perspective, the stock is trading at a discount (Forward PE: -30.2) compared to its historical average (126.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $18.82, while resistance sits at $20.88. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $37.91 (+91.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $18.82, while resistance sits at $20.88. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $37.91 (+91.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$19.50 -
$23.11
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding SNDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 91.8% below Wall St target ($37.91)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$19.50 -
$23.11
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$18.82
Resistance Level
$20.88
Current Trend
Strong Uptrend
Technical data as of
Aug 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-30.20
Wall Street Target
$37.91
(+91.8%)
Revenue Growth (YoY)
91.8%
Profit Margin
-87.5%
PE vs Historical
-30.2 vs 126.3
CHEAP
Share & Embed Analysis
Last updated: August 21, 2026 5:18 AM ET
Data refreshes hourly during market hours. Next update: 6:18 AM
Data refreshes hourly during market hours. Next update: 6:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 39 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1100 | 37 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 60 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 32 SELL |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 45 HOLD |
Advanced SNDX Option Strategies
Professional options setups generated by AI based on today's SNDX price and gamma walls.
